ArticleTranslational cancer research2019

The MEK inhibitors enhance the efficacy of sorafenib against hepatocellular carcinoma cells through reducing p-ERK rebound.

Wanting Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.